50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,617.81 (-2.72%)
DOW   29,042.39 (-2.16%)
QQQ   269.74 (-3.64%)
AAPL   141.48 (-5.58%)
MSFT   235.03 (-2.51%)
META   136.35 (-3.71%)
GOOGL   96.17 (-3.88%)
AMZN   113.45 (-3.86%)
TSLA   266.91 (-7.26%)
NVDA   120.04 (-5.75%)
NIO   15.46 (-10.79%)
BABA   78.05 (-3.63%)
AMD   63.58 (-6.99%)
T   15.46 (-2.34%)
MU   49.36 (-3.22%)
CGC   2.78 (-8.55%)
F   11.37 (-6.65%)
GE   62.01 (-3.80%)
DIS   96.33 (-3.09%)
AMC   7.03 (-8.34%)
PYPL   88.08 (-3.34%)
PFE   44.11 (-0.72%)
NFLX   236.66 (-3.48%)
S&P 500   3,617.81 (-2.72%)
DOW   29,042.39 (-2.16%)
QQQ   269.74 (-3.64%)
AAPL   141.48 (-5.58%)
MSFT   235.03 (-2.51%)
META   136.35 (-3.71%)
GOOGL   96.17 (-3.88%)
AMZN   113.45 (-3.86%)
TSLA   266.91 (-7.26%)
NVDA   120.04 (-5.75%)
NIO   15.46 (-10.79%)
BABA   78.05 (-3.63%)
AMD   63.58 (-6.99%)
T   15.46 (-2.34%)
MU   49.36 (-3.22%)
CGC   2.78 (-8.55%)
F   11.37 (-6.65%)
GE   62.01 (-3.80%)
DIS   96.33 (-3.09%)
AMC   7.03 (-8.34%)
PYPL   88.08 (-3.34%)
PFE   44.11 (-0.72%)
NFLX   236.66 (-3.48%)
S&P 500   3,617.81 (-2.72%)
DOW   29,042.39 (-2.16%)
QQQ   269.74 (-3.64%)
AAPL   141.48 (-5.58%)
MSFT   235.03 (-2.51%)
META   136.35 (-3.71%)
GOOGL   96.17 (-3.88%)
AMZN   113.45 (-3.86%)
TSLA   266.91 (-7.26%)
NVDA   120.04 (-5.75%)
NIO   15.46 (-10.79%)
BABA   78.05 (-3.63%)
AMD   63.58 (-6.99%)
T   15.46 (-2.34%)
MU   49.36 (-3.22%)
CGC   2.78 (-8.55%)
F   11.37 (-6.65%)
GE   62.01 (-3.80%)
DIS   96.33 (-3.09%)
AMC   7.03 (-8.34%)
PYPL   88.08 (-3.34%)
PFE   44.11 (-0.72%)
NFLX   236.66 (-3.48%)
S&P 500   3,617.81 (-2.72%)
DOW   29,042.39 (-2.16%)
QQQ   269.74 (-3.64%)
AAPL   141.48 (-5.58%)
MSFT   235.03 (-2.51%)
META   136.35 (-3.71%)
GOOGL   96.17 (-3.88%)
AMZN   113.45 (-3.86%)
TSLA   266.91 (-7.26%)
NVDA   120.04 (-5.75%)
NIO   15.46 (-10.79%)
BABA   78.05 (-3.63%)
AMD   63.58 (-6.99%)
T   15.46 (-2.34%)
MU   49.36 (-3.22%)
CGC   2.78 (-8.55%)
F   11.37 (-6.65%)
GE   62.01 (-3.80%)
DIS   96.33 (-3.09%)
AMC   7.03 (-8.34%)
PYPL   88.08 (-3.34%)
PFE   44.11 (-0.72%)
NFLX   236.66 (-3.48%)
NASDAQ:ENDP

Endo International - ENDP Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
N/A
50-Day Range
$0.28
$0.75
52-Week Range
N/A
Volume
1.49 million shs
Average Volume
28.19 million shs
Market Capitalization
$68.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50

Endo International MarketRank™ Forecast

Analyst Rating
Hold
1.67 Rating Score
Upside/​Downside
∞ Upside
$2.50 Price Target
Short Interest
Healthy
8.47% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.62
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-83.33%
From $0.78 to $0.13 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.87 out of 5 stars

Medical Sector

830th out of 1,096 stocks

Pharmaceutical Preparations Industry

406th out of 548 stocks

ENDP stock logo

About Endo International (NASDAQ:ENDP) Stock

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

Receive ENDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Endo International and its competitors with MarketBeat's FREE daily newsletter.

ENDP Stock News Headlines

ENDP.O
ENDPQ Endo International plc
Endo Int'l (ENDP) Stock Spikes as Biotech Rallies
Endo International PLC ENDP
Endo: End Game And What Burned Investors Can Learn
Drugmaker Endo Says Bankruptcy Likely Imminent
Endo Shares Plunge On Imminent Bankruptcy Filing
ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS
See More Headlines

Receive ENDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Endo International and its competitors with MarketBeat's FREE daily newsletter.

ENDP Company Calendar

Last Earnings
11/04/2021
Today
9/29/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NASDAQ:ENDP
CUSIP
29264F20
Employees
3,103
Year Founded
1997

Price Target and Rating

Average Stock Price Forecast
$2.50
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$1.00
Consensus Rating
Hold
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

Net Income
$-613,240,000.00
Pretax Margin
-91.14%

Debt

Sales & Book Value

Annual Sales
$2.99 billion
Book Value
($13.60) per share

Miscellaneous

Free Float
232,321,000
Market Cap
$68.19 million
Optionable
Optionable
Beta
1.15

Social Links


Key Executives

  • Mr. Blaise A. Coleman (Age 48)
    Pres, CEO & Director
    Comp: $20.93M
  • Mr. Mark T. Bradley (Age 52)
    Exec. VP & CFO
    Comp: $6.27M
  • Mr. Matthew Joseph Maletta (Age 50)
    Exec. VP, Chief Legal Officer & Company Sec.
    Comp: $7.02M
  • Mr. Patrick A. Barry (Age 54)
    Exec. VP & Pres of Global Commercial Operations
    Comp: $6.15M
  • Frank B. Raciti
    VP, Controller & Chief Accounting Officer
  • Ms. Cheryl Stouch
    Sr. VP of Information Technology & Chief Information Officer
  • Ms. Laure E. Park
    Sr. VP of Investor Relations & Corp. Affairs
  • Ms. Susan Williamson
    Sr. VP & Chief Compliance Officer
  • Ms. Tracy Basso
    Chief HR Officer
  • Mr. James Papp
    Head of Endo Ventures Limited & Sr. VP of Global Supply Chain













ENDP Stock - Frequently Asked Questions

Should I buy or sell Endo International stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Endo International in the last year. There are currently 2 sell ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ENDP shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ENDP, but not buy additional shares or sell existing shares.
View ENDP analyst ratings
or view top-rated stocks.

What is Endo International's stock price forecast for 2022?

3 Wall Street research analysts have issued 1-year target prices for Endo International's stock. Their ENDP share price forecasts range from $1.00 to $6.00. On average, they anticipate the company's share price to reach $2.50 in the next twelve months.
View analysts price targets for ENDP
or view top-rated stocks among Wall Street analysts.

When is Endo International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our ENDP earnings forecast
.

How were Endo International's earnings last quarter?

Endo International plc (NASDAQ:ENDP) announced its quarterly earnings data on Thursday, November, 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.34. The firm earned $772.03 million during the quarter, compared to analysts' expectations of $667.94 million. Endo International had a negative net margin of 93.31% and a negative trailing twelve-month return on equity of 34.25%. The firm's revenue was up 21.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.52 earnings per share.

What is Paul Campanelli's approval rating as Endo International's CEO?

25 employees have rated Endo International Chief Executive Officer Paul Campanelli on Glassdoor.com. Paul Campanelli has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Endo International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Endo International investors own include Teva Pharmaceutical Industries (TEVA), Bausch Health Companies (BHC), Mallinckrodt (MNK), Gilead Sciences (GILD), TherapeuticsMD (TXMD), Micron Technology (MU), Cleveland-Cliffs (CLF), Pfizer (PFE), Advanced Micro Devices (AMD) and NVIDIA (NVDA).

What is Endo International's stock symbol?

Endo International trades on the NASDAQ under the ticker symbol "ENDP."

How much money does Endo International make?

Endo International (NASDAQ:ENDP) has a market capitalization of $0.00 and generates $2.99 billion in revenue each year. The company earns $-613,240,000.00 in net income (profit) each year or ($11.07) on an earnings per share basis.

How many employees does Endo International have?

The company employs 3,103 workers across the globe.

How can I contact Endo International?

Endo International's mailing address is First Floor Minerva House Simmonscourt Road Ballsbridge, Dublin L2, 19355. The official website for the company is www.endo.com. The company can be reached via phone at (531) 268-2000, via email at relations.investor@endo.com, or via fax at 800-329-3636.

This page (NASDAQ:ENDP) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.